Semnur Pharmaceuticals, Inc. (SMNR)
SMNR is quoted over the counter, not listed on an exchange. Semnur Pharmaceuticals, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | SMNR, quoted over the counter |
| SEC CIK | 0001913577 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Palo Alto, CA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "As a result, management has concluded that the aforementioned conditions, among other things, raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the condensed consolidated financial statements are 7 issued." | 10-Q 2026-11-04 |
| Cash and burn | $54K cash; operating cash flow -$2.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 217,709,142 (2026-11-04); 229,740,978 a year earlier. | Cover page 2026-11-04 |
| Reverse splits, 3 years | 1; latest on 2025-09-26 | Source 2025-09-26 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-07-14 |
| Auditor | Pipara & Co LLP, New Delhi, India; changed auditors 1 time in 24 months | 8-K 4.01 2025-09-26 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | Not filed | -$3.6M | -$2.2M | $54K | $2.3M | Needs four quarters | 10-Q 2026-11-04 |
| Q2 2026 2026-06-30 | Not filed | -$4.3M | -$2.1M | $39K | $2.1M | Needs four quarters | 10-Q 2026-11-04 |
| Q1 2026 2026-03-31 | Not filed | -$4.6M | -$2.7M | $103K | $2.8M | Needs four quarters | 10-Q 2026-11-04 |
| Q4 2025 2025-12-31 | Not filed | -$6.2M | -$3.6M | $20K | $3.5M | Needs four quarters | 10-K 2026-02-27 |
| Q3 2025 2025-09-30 | Not filed | -$152.6M | -$2.1M | $85K | $4.5M | Needs four quarters | 10-Q 2026-11-04 |
| Q2 2025 2025-06-30 | Not filed | -$999K | $268K | $55K | $1.4M | Needs four quarters | 10-Q 2026-11-04 |
| Q1 2025 2025-03-31 | Not filed | -$665K | -$399K | $7K | $1.4M | Needs four quarters | 10-Q 2026-11-04 |
| Q4 2024 2024-12-31 | Not filed | -$167K | -$1.4M | $12K | $1.4M | Needs four quarters | 10-K 2025-04-02 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-07-07 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-11-04 |
| Latest current report | 8-K | 2026-07-07 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 221 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier